Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1996-03-21
1998-08-11
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
4242821, 424 9346, 5303872, A61K 4505, A01H 6300, C07K 1600
Patent
active
057924554
ABSTRACT:
A vaccine for stimulating and enhancing in a subject to which the vaccine is administered, production of antibodies which recognize GD3 ganglioside, comprising an effective amount of anti-idiotypic monoclonal antibody, designated BEC2, an effective amount of the appropriate adjuvant and a pharmaceutically acceptable vehicle.
REFERENCES:
patent: 5529922 (1996-06-01), Chapman et al.
Forstrom, et al., "Immunization To A Syngeneic Sarcoma By A Monoclonal Auto-anti-idiotypic Antibody", Nature, Jun. 1983, Nature, vol. 303, pp. 627-629 (Exhibit 17).
Hastings, et al., "Production And Characterization Of A Murine/Human Chimeric Anti-idiotype Antibody That Mimics Ganglioside", Cancer Research, Apr. 1992, vol. 52, pp. 1681-1686 (Exhibit 18).
Hellstrom, "Strong Antitumor Activities Of IgG3 Antibodies To A Human Melanoma-associated Ganglioside", PNAS, Mar. 1985, vol. 82, pp. 1499-1502 (Exhibit 19).
Hird, et al., "Immunotherapy With Monoclonal Antibodies", Genes and Cancer, 1990, pp. 183-189 (Exhibit 20).
Hodgson, "Making Monoclonals In Microbes", Biotechnology 1991, vol. 9, pp. 421-424 (Exhibit 21).
Houghton, et al., "Mouse Monoclonal IgG3 Antibody Detecting G.sub.D3 Ganglioside: A Phase I Trial In Patients With Malignant Melanoma", PNAS 1985, vol. 82, pp. 1242-1246 (Exhibit 22).
Kerlin, et al., "Variations In Immunoglobulin Isotype Produced During the Antibody Response To Brucella Abortus and Staphylococcus Aureus Vaccines In Sheep", Research in Veterinary Science, 1986, vol. 41, pp. 191-195 (Exhibit 23).
Koprowski, et al., "Human Anti-idiotype Antibodies In Cancer Patients: Is The Modulation Of The Immune Response Beneficial For The Patient?", PNAS, Jan. 1984, vol. 81, pp. 216-219 (Exhibit 24).
Livingston, et al., "Serological Response Of Melanoma Patients To Vaccines Prepared From VSV Lysates Of Autologous And Allogenic Cultured Melanoma Cells", Cancer 1985, vol. 55, pp. 713-720 (Exhibit 25).
Miller, et al., "Shared Idiotypes Expressed By Human B-Cell Lymphomas", New England Journal of Medicine, 1989, vol. 321, No. 13, pp. 851-857 (Exhibit 26).
Morrison, et al., "Transfectomas Provide Novel Chimeric Antibodies", Science 1985, vol. 229, pp. 1202-1207 (Exhibit 27).
Morrison, et al., "Production And Characterization Of Genetically Engineered Antibody Molecules", Clinical Chemistry, 1988, vol. 34, pp. 1668-1675 (Exhibit 28).
Nepom, et al., "Anti-idiotypic Antibodies And The Induction Of Specific Tumor Immunity", Cancer and Metastasis Reviews, 1987, vol. 6. pp. 489-502 (Exhibit 29).
Nepom, et al., "Induction Of Immunity To A Human Tumor Marker By In Vivo Administration Of Anti-idiotypic Antibodies In Mice", PNAS, vol. 81, May 1984, pp. 2864-2867 (Exhibit 30).
Oi, et al., "Chimeric Antibodies", Biotechniques 1986, vol. 4, pp. 214-221 (Exhibit 31).
Saroj Vadhan-Raj, et al., "Phase I Trial Of A Mouse Monoclonal Antibody Against GD3 Ganglioside In Patients With Melanoma: Induction Of Inflamatory Response At Tumor Sites", Journal of Clinical Oncology 1988, vol. 6, No. 10, pp. 1636-1648 (Exhibit 33).
Schreiber, et al., "Anti-Idiotype Induced, LPS-Specific Antibody Response To Pseudomonas Aeruginosa", Clinical Research, 1988, vol. 36, No. 3 (Exhibit 34).
Shin, "Production And Properties Of Chimeric Antibody Molecules", Methods in Enzymology, 1989, vol. 178, pp. 459-476 (Exhibit 35).
Soederstroem, et al., "The Escherichia Coli K1 Capsule Shares Antigenic Determinants With The Human Gangliosides GM3 and GD3", Chemical Abstracts, Jun. 1984, vol. 100, p. 425 (Exhibit 36).
Staruch, et al., "The Adjuvanticity Of Interleukin 1 In Vivo", Journal of Immunology 1983, vol. 130, pp. 2191-2194 (Exhibit 37).
Stein, "Neonatal Administration Of Idiotype Or Antidiotype Primes For Protection Against Escheria Coli K13 Infection In Mice", Journal of Experimental Medicine 1984, vol. 160, pp. 1001-1011 (Exhibit 38).
Tadashi, T., et al., "Immunogenicity Of Melanoma-associated Gangliosides In Cancer Patients", In. J. Cancer, 1985, vol. 35, pp. 607-612 (Exhibit 39).
Viale, et al., "Anti-human Tumor Antibodies Induced In Mice And Rabbits By Internal Image Anti-idiotypic Monoclonal Immunoglobulins", J. Immunology, Dec. 15, 1987, vol. 139, pp. 4250-4255 (Exhibit 40).
Viale, et al., "Idiotypic Replica Of An Anti-Human Tumor 15, Associated Antigen Monoclonal Antibody", J. Immunology, Dec. 1989, vol. 143, pp. 4338-4344 (Exhibit 41).
Yeh, et al., "Mouse Monoclonal Anti-Idiotypic Antibody To MG-21, A Mouse IgG3 Monoclonal Antibody To A Human Melanoma-Associated GD3 Ganglioside Antigen", Proceedings of AACR, Mar. 1987, vol. 28, p. 388, Abstract No. 1538 (Exhibit 42).
Young, et al., "Production Of Monoclonal Antibodies Specific For Two Distinct Steric Portions Of The Glycolipid Ganglio-N-Triosylceramide", Oct. 1979, Journal of Experimental Medicine, vol. 150, pp. 1008-1019 (Exhibit 43).
Waldmann, T., "Monoclonal Antibodies In Diagnosis And Therapy", Science, Jun. 1991, vol. 252, pp. 1657-1662 (Exhibit 44).
Wei, et al., "Improved Anti-tumor Reactivity With Monoclonal Anti-idiotypic Antibody Conjugated To Syngeneic Mouse Red Blood Cells", J. Immunology Methods, 1989, vol. 122, pp. 227-234 (Exhibit 45).
Cheresh, et al., "Disialoganglioside GD3 On Human Melanoma Serves As A Relevant Target Antigen For Monoclonal Antibody-mediated Tumor Cytolysis"PNAS 1985, vol. 82, pp. 5155-5159 (Exhibit 14).
Davis, et al., "Antibody and HIV-1 gp120 Recognition Of CD4 Undermines The Concept of Mimicry Between Antibodies And Receptors", Nature 1992, vol. 358, pp. 76-79 (Exhibit 15).
Dippold, et al., "Cell Surface Antigens Of Human Malignant Melanoma: Definition Of Six Antigenic Systems With Mouse Monoclonal Antibodies", PNAS, 1980, vol. 77:10, pp. 6114-6118 (Exhibit 16).
Chapman Paul B.
Houghton Alan N.
Bansal Geetha P.
Feisee Lila
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Anti-idiotypic antibody vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-idiotypic antibody vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-idiotypic antibody vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-386445